Theriva Biologics, Inc. (TOVX) Misses Q3 EPS by 652c

Theriva Biologics, Inc. (NYSE: TOVX) reported Q3 EPS of ($6.81), $6.52 worse than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Theriva Biologics, Inc. (TOVX) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Btig warns stock investors on seasonal weakness ahead in election year
• BofA sees dollar weakness continuing with New Zealand dollar gains